Index of All HIV and AIDS Articles by Topic ( A to Z)
Index of All Hepatitis C Articles by Topic ( A to Z)

HBeAg Clearance Linked to HBV Pre-core and Core Mutations

Interaction between hepatitis B virus (HBV) and the host immune system is critical to the outcome of HBV infection, as the balance between HBV-specific immune response and viral replication influence the course of disease. Selective immune pressure may be associated with the emergence of mutations within pre-core and core regions of HBV that affect successful control of viral replication.

As reported at the recent annual meeting of the American Association for the Study of Liver Diseases (AASLD), researchers from King's College London School of Medicine conducted a study to investigate the presence of HBV pre-core and core mutations in children with hepatitis B, and their relation to viral replication and HBV "e" antigen (HBeAg) clearance.

The study included 69 children (median age 13.25 years) divided into 5 groups according to the presence or absence of HBeAg, HBV surface antigen (HBsAg), and alanine aminotransferase (ALT) levels:

Group A (immunotolerant):HBsAg+, HBeAg+, normal ALT (n = 33);
Group B (immunoactive): HBsAg+, HBeAg+, elevated ALT (n = 17);
Group C (low HBV replication):- HBsAg+, HBeAg-, normal ALT (n = 13);
Group D (HBeAg negative chronic hepatitis B): HBsAg+, HBeAg-, elevated ALT (n = 2);
Group E (self-limited hepatitis B): HBsAg-, HBeAg-, normal ALT (n = 4).


HBV DNA was isolated from patients' serum samples. The presence of point mutations within HBV pre-core and core promoter regions and amino acid substitutions within immunodominant epitopes of HBV core gene were analyzed by direct sequencing. HBV DNA viral load was quantified using real-time PCR.

Results

HBV DNA viral load was significantly higher in groups A, B, and D when compared with groups C and E (P = 0.001).

The total number of point mutations within HBV pre-core and core promoter regions and the number of amino acid substitutions within the immunodominant epitopes of HBV core gene were higher in HBeAg negative patients compared with HBeAg positive children (P = 0.001 and 0.055, respectively).

There was a strong inverse correlation between the number of pre-core and core regions mutations and the presence of HBeAg (r = -0.628, P = 0.001 and r = -0.341, P = 0.005, respectively).

Results as mean ± SEM are presented in the table below.

Group

HBV DNA

Pre-core region

Core region

A

7.89 ± 0.22

2.17 ± 0.23

4.82 ± 0.38

B

6.81 ± 0.52

2.27 ± 0.40

5.88 ± 0.75

C

3.94 ± 0.26

5.42 ± 0.33

6.54 ± 0.48

D

7.45 ± 1.23

6.5 ± 0.50

8.00 ± 0.00

E

0

ND

ND

Conclusion

In conclusion, the researchers wrote, "Clearance of HBeAg is associated with a high number of mutations within pre-core and core regions of HBV, suggesting that the selective pressure of the immune system on hepatitis B virus is responsible for the emergence of mutations within HBV pre-core and core regions."

Institute of Liver Studies, King's College London School of Medicine, London, England, UK.

11/17/06

Reference
I Carey, A Giannattasio, S Bansal, and others. Clearance of HBeAg is linked with emergence of mutations within pre-core and core regions of hepatitis B virus in paediatric patients. 57th AASLD. Boston, MA. October 27-31, 2006. Abstract 671.



Google_______________


 

 


Conference
Main Page


Hepatitis C
FDA-Approved
Treatments

Monotherapies
Intron A
Roferon
Infergen
Pegasys
PEG-Intron


Combination
Pegasys + Copegus
PEG-Intron + Rebetol
Intron A + Rebetol
Roferon A + Ribavirin

Hepatitis B
FDA-Approved
Treatments

Baraclude
Epivir-HBV
Hepsera
Intron A
Pegasys
Tyzeka